This scientific paper was published in Experiment Biology and Medicine Journal and led by the U.S. Food and Drug Administration. It summarized selected presentations from the Global Summit on Regulatory Science (GSRS20), and highlighted the importance for regulatory community to work closely with the technology developers for emerging global regulatory challenges. Dr. Yan Liu (MD and PhD), Chief Medical Officer at Median Technologies was selected to participate in the elaboration of this paper.